Sign In  |  Register  |  About Menlo Park  |  Contact Us

Menlo Park, CA
September 01, 2020 1:28pm
7-Day Forecast | Traffic
  • Search Hotels in Menlo Park

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:

Newly approved monkeypox vaccine by Japan's KM Biologics sees immediate overseas demand

A new monkeypox vaccine, manufactured by KM Biologics Co, a Japanese pharmaceutical company, is garnering overseas interest as the disease spreads around the globe.

Japanese pharmaceuticals company KM Biologics Co has already seen overseas interest in its monkeypox vaccine which was recently approved by domestic regulators.

KM Biologics, a unit of candy maker Meiji Holdings Co, has had "several inquiries from overseas" a company official told Reuters on Wednesday, declining to comment on any export plan for the shot.

Japan's health ministry on Tuesday approved the company's freeze-dried smallpox vaccine LC16 KMB for use against monkeypox, after an experts panel recommended the move last week.

Japan has had only two confirmed cases of monkeypox during the current global outbreak.

MONKEYPOX: WHAT YOU MUST KNOW ABOUT THE VIRUS — AND HOW TO PROTECT YOURSELF

Based in the southern prefecture of Kumamoto, KM Biologics mainly produces vaccines for humans and veterinary use. It has an inactivated COVID-19 shot currently in development.

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
Copyright © 2010-2020 MenloPark.com & California Media Partners, LLC. All rights reserved.